Dapagliflozin Tablets 5 mg, 10 mg

Dapagliflozin Tablets 5 mg, 10 mg

Product Name :

Sacubitril + Valsartan Tablets 24mg/26mg, 49mg/51 Mg, 97mg/103mg Tablet

Available Strength :

Sacubitril 24 mg + Valsartan 26 mg; Sacubitril 49 mg + Valsartan 51 mg; Sacubitril 97 mg + Valsartan 103 mg

Packing :

3x10 Alu-Alu Blister / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Heart failure therapy

Production Capacity :

10 Million Tablets/Month

Description:

What is Dapagliflozin Tablets 5 mg, 10 mg?

Dapagliflozin Tablets 5 mg and 10 mg contain dapagliflozin, an oral medicine used as part of the management of type 2 diabetes and, where approved, certain cardiovascular and kidney-related conditions. It belongs to the sodium-glucose cotransporter-2 (SGLT2) inhibitor class and helps reduce blood glucose by increasing glucose excretion through urine.

Uses / Indications

Dapagliflozin tablets may be used, according to the approved product information, for:

  • Management of type 2 diabetes mellitus along with appropriate diet and physical activity.
  • Use as monotherapy when suitable or in combination with other glucose-lowering medicines.
  • Cardiovascular risk management in certain eligible patients, where the indication is approved.
  • Management of certain chronic kidney disease conditions in eligible patients, where approved.
  • Management of heart failure in specific patient populations, according to applicable prescribing information.

Benefits

  • Helps lower blood glucose by increasing urinary glucose excretion.
  • Provides an oral treatment option for appropriate patients with type 2 diabetes.
  • Can be used alone or in combination with other glucose-lowering medicines when clinically appropriate.
  • Its SGLT2 inhibitor mechanism may provide additional cardiovascular or renal benefits in approved patient populations.
  • Available in 5 mg and 10 mg strengths to support different prescribing requirements.

Side Effects

Common Side Effects

Possible side effects may include:

  • Increased urination
  • Genital fungal infections
  • Urinary tract infections
  • Increased thirst
  • Dizziness, particularly with fluid loss
  • Headache
  • Changes in bowel habits or gastrointestinal discomfort

Less Common or Serious Side Effects

Important but less common reactions may include:

  • Dehydration or low blood pressure
  • Diabetic ketoacidosis, which can occasionally occur even when blood glucose is not markedly elevated
  • Serious urinary or genital infections
  • Acute kidney injury or worsening renal function in susceptible patients
  • Severe hypersensitivity reactions
  • Necrotizing infection of the perineum, rarely

Seek urgent medical attention if symptoms such as severe weakness, difficulty breathing, persistent vomiting, abdominal pain, confusion, severe dizziness, or symptoms of a serious infection occur.

How Does It Work?

Dapagliflozin selectively inhibits SGLT2, a transporter responsible for reabsorbing glucose from the kidneys back into the bloodstream. By reducing this reabsorption, dapagliflozin increases the amount of glucose eliminated in the urine, helping lower blood glucose levels. The increased urinary glucose excretion also produces an osmotic diuretic effect.

Dosage Guidelines

The appropriate dose depends on the approved indication, kidney function, age, concurrent medicines, clinical response, and individual patient factors.

  • Take the tablet exactly as prescribed by a qualified healthcare professional.
  • It may generally be taken with or without food.
  • Take the medicine at approximately the same time each day.
  • Maintain adequate fluid intake unless a healthcare professional has advised otherwise.
  • Do not alter, discontinue, or increase the dose without professional guidance.
  • The 5 mg and 10 mg strengths should be selected according to the approved indication and prescribing information.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Dapagliflozin should not be used in patients with:

  • Known hypersensitivity to dapagliflozin or any component of the product.
  • Diabetic ketoacidosis or suspected ketoacidosis.
  • Certain degrees of severe renal impairment where use is not recommended or indicated.
  • Other conditions in which the approved prescribing information specifically contraindicates treatment.

Use should also be carefully assessed during acute illness, prolonged fasting, major surgery, or significant fluid loss.

Drug / Product Interactions

Clinically relevant interactions may include:

  • Insulin and insulin secretagogues: May increase the risk of hypoglycemia.
  • Diuretics: May increase urine output and the risk of dehydration or low blood pressure.
  • Medicines affecting renal function: May require additional clinical monitoring.
  • Other glucose-lowering medicines: Blood glucose effects may require monitoring and dose adjustment.
  • Medicines associated with fluid or blood-pressure changes: Additional monitoring may be appropriate.

Safety Advice

  • Monitor blood glucose according to the treatment plan.
  • Maintain adequate hydration, particularly during periods of increased fluid loss.
  • Inform the healthcare professional before surgery or prolonged fasting.
  • Seek medical attention if symptoms suggest diabetic ketoacidosis, even if blood glucose is not extremely high.
  • Monitor for symptoms of urinary or genital infections.
  • Kidney function should be assessed as clinically appropriate.
  • Alcohol consumption should be discussed with a healthcare professional because excessive alcohol intake may increase certain metabolic risks.
  • During pregnancy or breastfeeding, use only when specifically recommended by a qualified healthcare professional.
  • Children and adolescents should receive dapagliflozin only for approved indications and according to applicable prescribing information.
  • Older adults and patients with reduced kidney function may require additional monitoring.

If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

For a missed dose, take it when remembered unless it is close to the next scheduled dose. Do not take a double dose to compensate for a missed dose.

General Instructions

  • Use dapagliflozin only according to the approved product information.
  • Take the tablet regularly as prescribed.
  • Do not stop treatment without consulting a healthcare professional.
  • Follow the recommended diet, exercise, and blood glucose monitoring plan.
  • Inform healthcare professionals about all prescription medicines, non-prescription medicines, and supplements being used.
  • Report persistent dehydration, recurrent infections, or unusual symptoms promptly.

Special Dietary / Lifestyle Tips

  • Follow a balanced diet appropriate for diabetes management.
  • Maintain adequate fluid intake unless fluid restriction has been prescribed.
  • Regular physical activity may support blood glucose management when medically appropriate.
  • Avoid excessive alcohol consumption.
  • Maintain appropriate personal hygiene to help reduce the risk of genital and urinary infections.
  • Monitor blood glucose as recommended, particularly when dapagliflozin is combined with other glucose-lowering medicines.

Comparison with Other Treatments

Dapagliflozin differs from other glucose-lowering medicines because it primarily lowers blood glucose by increasing urinary glucose excretion through SGLT2 inhibition. Metformin primarily reduces hepatic glucose production and improves insulin sensitivity, while sulfonylureas stimulate insulin release. Insulin directly replaces or supplements endogenous insulin. The appropriate treatment depends on the patient’s diagnosis, kidney function, cardiovascular and renal status, other medicines, tolerability, and treatment goals.

Precautions & Warnings

  • Assess kidney function before and during treatment as appropriate.
  • Monitor for volume depletion, particularly in patients taking diuretics or those at increased risk of dehydration.
  • Consider the risk of diabetic ketoacidosis during prolonged fasting, acute illness, surgery, or significant reduction in insulin.
  • Report symptoms of urinary or genital infection promptly.
  • Use caution in patients with conditions that may predispose them to dehydration or low blood pressure.
  • Dapagliflozin is not a substitute for insulin in patients who require insulin therapy.
  • Treatment decisions during pregnancy, breastfeeding, acute illness, or major surgery should be made by a qualified healthcare professional.

Can I Use It With Other Medicines?

Generally Compatible With

Dapagliflozin may be prescribed with other glucose-lowering medicines, including metformin, insulin, or selected oral antidiabetic medicines, when clinically appropriate.

Use With Caution / Avoid

  • Insulin or insulin secretagogues may increase hypoglycemia risk.
  • Diuretics may increase the risk of dehydration and low blood pressure.
  • Other medicines affecting kidney function or fluid balance may require monitoring.
  • Excessive alcohol intake should be avoided or discussed with a healthcare professional.
  • Always inform the prescriber or pharmacist about all medicines and supplements being used.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

  • Keep the tablets in the original packaging until use.
  • Protect the product from excessive heat, moisture, and light where applicable.
  • Keep out of reach of children.
  • Do not use after the expiry date.
  • Follow any additional storage instructions provided on the approved product label.

Frequently Asked Questions

1. What is Dapagliflozin Tablets 5 mg, 10 mg used for?

Dapagliflozin is primarily used for the management of type 2 diabetes and may also have approved cardiovascular or kidney-related indications in certain patient populations.

2. How does dapagliflozin lower blood glucose?

It inhibits SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose elimination through urine.

3. Are 5 mg and 10 mg dapagliflozin tablets interchangeable?

The strengths are not automatically interchangeable. The appropriate strength depends on the approved indication, kidney function, treatment response, and prescribing instructions.

4. Can dapagliflozin be taken with metformin?

Dapagliflozin can be prescribed with metformin when combination treatment is clinically appropriate. The combination should be used according to professional prescribing guidance.

5. Does dapagliflozin increase urination?

Yes. Because the medicine increases glucose and associated water excretion through urine, some patients may experience increased urination.

6. What should I do if I miss a dose?

Take the missed dose when remembered unless it is close to the next scheduled dose. Do not double the next dose.

7. Can dapagliflozin be used during pregnancy?

Dapagliflozin should generally be used during pregnancy only when specifically recommended by a qualified healthcare professional based on the approved product information.

8. How should Dapagliflozin Tablets be stored?

Store the product according to the storage conditions stated on the approved product label and package insert, keeping it in its original packaging and out of reach of children.

Scroll to Top